About
1.21USD-0.02 -1.63%
Closed • Updated at 00:25 GMT+00:00Market Cap$74.92M
Volume212.1K
Beta1.34
RSI48.81
Pliant Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 21 2026
Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 11 2026
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 6 2026
Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
Apr 30 2026
Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
Apr 18 2026
Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
Community Chat
Ask AI
Try asking
Google Übersetzer